These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
142 related items for PubMed ID: 21393476
1. Functional variants of -1318T > G and -673C > T in c-Jun promoter region associated with increased colorectal cancer risk by elevating promoter activity. Chen D, Song S, Lu J, Luo Y, Yang Z, Huang Q, Fu X, Fan X, Wei Y, Wang J, Wang L. Carcinogenesis; 2011 Jul; 32(7):1043-9. PubMed ID: 21393476 [Abstract] [Full Text] [Related]
2. Functional genetic variants of c-Jun and their interaction with smoking and drinking increase the susceptibility to lung cancer in southern and eastern Chinese. Huang B, Liu B, Yang L, Li Y, Cheng M, Huang D, Wang H, Zhang X, Zheng J, Li Q, Ji W, Zhou Y, Lu J. Int J Cancer; 2012 Sep 01; 131(5):E744-58. PubMed ID: 22189957 [Abstract] [Full Text] [Related]
3. Genotype and haplotype analysis of cell cycle genes in sporadic colorectal cancer in the Czech Republic. Polakova V, Pardini B, Naccarati A, Landi S, Slyskova J, Novotny J, Vodickova L, Bermejo JL, Hanova M, Smerhovsky Z, Tulupova E, Kumar R, Hemminki K, Vodicka P. Hum Mutat; 2009 Apr 01; 30(4):661-8. PubMed ID: 19224585 [Abstract] [Full Text] [Related]
4. Caspase 9 promoter polymorphisms and risk of primary lung cancer. Park JY, Park JM, Jang JS, Choi JE, Kim KM, Cha SI, Kim CH, Kang YM, Lee WK, Kam S, Park RW, Kim IS, Lee JT, Jung TH. Hum Mol Genet; 2006 Jun 15; 15(12):1963-71. PubMed ID: 16687442 [Abstract] [Full Text] [Related]
5. Methyl-CpG binding domain 1 gene polymorphisms and risk of primary lung cancer. Jang JS, Lee SJ, Choi JE, Cha SI, Lee EB, Park TI, Kim CH, Lee WK, Kam S, Choi JY, Kang YM, Park RW, Kim IS, Cho YL, Jung TH, Han SB, Park JY. Cancer Epidemiol Biomarkers Prev; 2005 Nov 15; 14(11 Pt 1):2474-80. PubMed ID: 16284366 [Abstract] [Full Text] [Related]
6. The association of XPC polymorphisms and tea drinking with colorectal cancer risk in a Chinese population. Wu Y, Jin M, Liu B, Liang X, Yu Y, Li Q, Ma X, Yao K, Chen K. Mol Carcinog; 2011 Mar 15; 50(3):189-98. PubMed ID: 21104992 [Abstract] [Full Text] [Related]
7. Methylenetetrahydrofolate reductase gene polymorphisms and the risk of colorectal carcinoma in a sample of Egyptian individuals. El Awady MK, Karim AM, Hanna LS, El Husseiny LA, El Sahar M, Menem HA, Meguid NA. Cancer Biomark; 2009 Mar 15; 5(6):233-40. PubMed ID: 20037199 [Abstract] [Full Text] [Related]
8. MTHFR and MTRR genotype and haplotype analysis and colorectal cancer susceptibility in a case-control study from the Czech Republic. Pardini B, Kumar R, Naccarati A, Prasad RB, Forsti A, Polakova V, Vodickova L, Novotny J, Hemminki K, Vodicka P. Mutat Res; 2011 Mar 18; 721(1):74-80. PubMed ID: 21211571 [Abstract] [Full Text] [Related]
11. Interleukin promoter polymorphisms and prognosis in colorectal cancer. Wilkening S, Tavelin B, Canzian F, Enquist K, Palmqvist R, Altieri A, Hallmans G, Hemminki K, Lenner P, Försti A. Carcinogenesis; 2008 Jun 18; 29(6):1202-6. PubMed ID: 18448485 [Abstract] [Full Text] [Related]
12. Functional haplotypes in the promoter of matrix metalloproteinase-2 predict risk of the occurrence and metastasis of esophageal cancer. Yu C, Zhou Y, Miao X, Xiong P, Tan W, Lin D. Cancer Res; 2004 Oct 15; 64(20):7622-8. PubMed ID: 15492291 [Abstract] [Full Text] [Related]
13. [Association of TP53 gene polymorphisms with genetic susceptibility to liver metastases of colorectal cancer]. Wang AZ, Zhu ZZ, Cong WM. Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr 15; 25(2):168-71. PubMed ID: 18393238 [Abstract] [Full Text] [Related]
14. Insulin pathway related genes and risk of colorectal cancer: INSR promoter polymorphism shows a protective effect. Pechlivanis S, Pardini B, Bermejo JL, Wagner K, Naccarati A, Vodickova L, Novotny J, Hemminki K, Vodicka P, Försti A. Endocr Relat Cancer; 2007 Sep 15; 14(3):733-40. PubMed ID: 17914103 [Abstract] [Full Text] [Related]
17. A polymorphism in the APE1 gene promoter is associated with lung cancer risk. Lo YL, Jou YS, Hsiao CF, Chang GC, Tsai YH, Su WC, Chen KY, Chen YM, Huang MS, Hu CY, Chen CJ, Hsiung CA. Cancer Epidemiol Biomarkers Prev; 2009 Jan 15; 18(1):223-9. PubMed ID: 19124501 [Abstract] [Full Text] [Related]
18. Functional haplotypes in the promoter of matrix metalloproteinase-2 and lung cancer susceptibility. Zhou Y, Yu C, Miao X, Wang Y, Tan W, Sun T, Zhang X, Xiong P, Lin D. Carcinogenesis; 2005 Jun 15; 26(6):1117-21. PubMed ID: 15731163 [Abstract] [Full Text] [Related]
19. Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer. Zhang X, Miao X, Tan W, Ning B, Liu Z, Hong Y, Song W, Guo Y, Zhang X, Shen Y, Qiang B, Kadlubar FF, Lin D. Gastroenterology; 2005 Aug 15; 129(2):565-76. PubMed ID: 16083713 [Abstract] [Full Text] [Related]
20. Effect of COX2 -765G>C and c.3618A>G polymorphisms on the risk and survival of sporadic colorectal cancer. Iglesias D, Nejda N, Azcoita MM, Schwartz S, González-Aguilera JJ, Fernández-Peralta AM. Cancer Causes Control; 2009 Oct 15; 20(8):1421-9. PubMed ID: 19468846 [Abstract] [Full Text] [Related] Page: [Next] [New Search]